APO Research
Talk to an analyst

APO RESEARCH · REPORT

Concentrated Angelica Pills

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Concentrated Angelica Pills Market Outlook and Growth Opportunities 2026

30 December 2025196 pages

Choose your research edition.

Industry ResearchConcentrated Angelica Pills Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Concentrated Angelica Pills Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Concentrated Angelica Pills Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Concentrated Angelica Pills Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Concentrated Angelica Pills Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Concentrated Angelica Pills market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Concentrated Angelica Pills is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Concentrated Angelica Pills is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Concentrated Angelica Pills is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Concentrated Angelica Pills market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Concentrated Angelica Pills market include BAOSHANG GROUP, Beijing Hygeia Medical Technique, BEIJING TONG REN TANG, Gansu Hexi Pharmaceutical, Gansu Minzhou Industrial Group, Gansu Pharmaceutical Group, Guangdong Fengchun Pharmaceutical, Lanzhou Foci Pharmaceutical and Zhongjing Wanxi Pharmacentical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Concentrated Angelica Pills market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Concentrated Angelica Pills and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Concentrated Angelica Pills sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Concentrated Angelica Pills market size, projected growth trends, production technologies, key applications, and end-use industries.

Concentrated Angelica Pills Segment by Company

BAOSHANG GROUP

Beijing Hygeia Medical Technique

BEIJING TONG REN TANG

Gansu Hexi Pharmaceutical

Gansu Minzhou Industrial Group

Gansu Pharmaceutical Group

Guangdong Fengchun Pharmaceutical

Lanzhou Foci Pharmaceutical

Zhongjing Wanxi Pharmacentical

Concentrated Angelica Pills Segment by Type

Eastern Danggui

European Danggui

Concentrated Angelica Pills Segment by Application

Hospital

Clinic

Pharmacy

Concentrated Angelica Pills Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Concentrated Angelica Pills status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Concentrated Angelica Pills market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Concentrated Angelica Pills significant trends, drivers, influence factors in global and regions.

6. To analyze Concentrated Angelica Pills competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Concentrated Angelica Pills market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Concentrated Angelica Pills and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Concentrated Angelica Pills.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Concentrated Angelica Pills market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Concentrated Angelica Pills industry.

Chapter 3: Detailed analysis of Concentrated Angelica Pills manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Concentrated Angelica Pills in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Concentrated Angelica Pills in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Concentrated Angelica Pills Industry Trends Table 2. Concentrated Angelica Pills Industry Drivers Table 3. Concentrated Angelica Pills Industry Opportunities and Challenges Table 4. Concentrated Angelica Pills Industry Restraints Table 5. Global Concentrated Angelica Pills Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Concentrated Angelica Pills Revenue Share by Company (2021-2026) Table 7. Global Concentrated Angelica Pills Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Concentrated Angelica Pills Sales Volume Share by Company (2021-2026) Table 9. Global Concentrated Angelica Pills Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Concentrated Angelica Pills Company Ranking, (2024-2026) & (USD Million) Table 11. Global Concentrated Angelica Pills Key Company Manufacturing Base & Headquarters Table 12. Global Concentrated Angelica Pills Company, Product Type & Application Table 13. Global Concentrated Angelica Pills Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Concentrated Angelica Pills by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Eastern Danggui Table 18. Significant Companies of European Danggui Table 19. Global Concentrated Angelica Pills Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Concentrated Angelica Pills Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Concentrated Angelica Pills Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Concentrated Angelica Pills Sales Volume Share by Type (2021-2026) Table 23. Global Concentrated Angelica Pills Sales Volume Share by Type (2027-2032) Table 24. Global Concentrated Angelica Pills Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Concentrated Angelica Pills Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Concentrated Angelica Pills Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Concentrated Angelica Pills Sales Value Share by Type (2021-2026) Table 28. Global Concentrated Angelica Pills Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Clinic Table 31. Significant Companies of Pharmacy Table 32. Global Concentrated Angelica Pills Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Concentrated Angelica Pills Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Concentrated Angelica Pills Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Concentrated Angelica Pills Sales Volume Share by Application (2021-2026) Table 36. Global Concentrated Angelica Pills Sales Volume Share by Application (2027-2032) Table 37. Global Concentrated Angelica Pills Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Concentrated Angelica Pills Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Concentrated Angelica Pills Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Concentrated Angelica Pills Sales Value Share by Application (2021-2026) Table 41. Global Concentrated Angelica Pills Sales Value Share by Application (2027-2032) Table 42. Global Concentrated Angelica Pills Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Concentrated Angelica Pills Sales by Region (2021-2026) & (K Units) Table 44. Global Concentrated Angelica Pills Sales Market Share by Region (2021-2026) Table 45. Global Concentrated Angelica Pills Sales by Region (2027-2032) & (K Units) Table 46. Global Concentrated Angelica Pills Sales Market Share by Region (2027-2032) Table 47. Global Concentrated Angelica Pills Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Concentrated Angelica Pills Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Concentrated Angelica Pills Sales Value Share by Region (2021-2026) Table 50. Global Concentrated Angelica Pills Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Concentrated Angelica Pills Sales Value Share by Region (2027-2032) Table 52. Global Concentrated Angelica Pills Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Concentrated Angelica Pills Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Concentrated Angelica Pills Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Concentrated Angelica Pills Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Concentrated Angelica Pills Sales by Country (2021-2026) & (K Units) Table 57. Global Concentrated Angelica Pills Sales Market Share by Country (2021-2026) Table 58. Global Concentrated Angelica Pills Sales by Country (2027-2032) & (K Units) Table 59. Global Concentrated Angelica Pills Sales Market Share by Country (2027-2032) Table 60. Global Concentrated Angelica Pills Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Concentrated Angelica Pills Sales Value Market Share by Country (2021-2026) Table 62. Global Concentrated Angelica Pills Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Concentrated Angelica Pills Sales Value Market Share by Country (2027-2032) Table 64. BAOSHANG GROUP Company Information Table 65. BAOSHANG GROUP Business Overview Table 66. BAOSHANG GROUP Concentrated Angelica Pills Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. BAOSHANG GROUP Concentrated Angelica Pills Product Portfolio Table 68. BAOSHANG GROUP Recent Development Table 69. Beijing Hygeia Medical Technique Company Information Table 70. Beijing Hygeia Medical Technique Business Overview Table 71. Beijing Hygeia Medical Technique Concentrated Angelica Pills Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Beijing Hygeia Medical Technique Concentrated Angelica Pills Product Portfolio Table 73. Beijing Hygeia Medical Technique Recent Development Table 74. BEIJING TONG REN TANG Company Information Table 75. BEIJING TONG REN TANG Business Overview Table 76. BEIJING TONG REN TANG Concentrated Angelica Pills Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. BEIJING TONG REN TANG Concentrated Angelica Pills Product Portfolio Table 78. BEIJING TONG REN TANG Recent Development Table 79. Gansu Hexi Pharmaceutical Company Information Table 80. Gansu Hexi Pharmaceutical Business Overview Table 81. Gansu Hexi Pharmaceutical Concentrated Angelica Pills Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Gansu Hexi Pharmaceutical Concentrated Angelica Pills Product Portfolio Table 83. Gansu Hexi Pharmaceutical Recent Development Table 84. Gansu Minzhou Industrial Group Company Information Table 85. Gansu Minzhou Industrial Group Business Overview Table 86. Gansu Minzhou Industrial Group Concentrated Angelica Pills Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Gansu Minzhou Industrial Group Concentrated Angelica Pills Product Portfolio Table 88. Gansu Minzhou Industrial Group Recent Development Table 89. Gansu Pharmaceutical Group Company Information Table 90. Gansu Pharmaceutical Group Business Overview Table 91. Gansu Pharmaceutical Group Concentrated Angelica Pills Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Gansu Pharmaceutical Group Concentrated Angelica Pills Product Portfolio Table 93. Gansu Pharmaceutical Group Recent Development Table 94. Guangdong Fengchun Pharmaceutical Company Information Table 95. Guangdong Fengchun Pharmaceutical Business Overview Table 96. Guangdong Fengchun Pharmaceutical Concentrated Angelica Pills Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Guangdong Fengchun Pharmaceutical Concentrated Angelica Pills Product Portfolio Table 98. Guangdong Fengchun Pharmaceutical Recent Development Table 99. Lanzhou Foci Pharmaceutical Company Information Table 100. Lanzhou Foci Pharmaceutical Business Overview Table 101. Lanzhou Foci Pharmaceutical Concentrated Angelica Pills Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Lanzhou Foci Pharmaceutical Concentrated Angelica Pills Product Portfolio Table 103. Lanzhou Foci Pharmaceutical Recent Development Table 104. Zhongjing Wanxi Pharmacentical Company Information Table 105. Zhongjing Wanxi Pharmacentical Business Overview Table 106. Zhongjing Wanxi Pharmacentical Concentrated Angelica Pills Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Zhongjing Wanxi Pharmacentical Concentrated Angelica Pills Product Portfolio Table 108. Zhongjing Wanxi Pharmacentical Recent Development Table 109. Key Raw Materials Table 110. Raw Materials Key Suppliers Table 111. Concentrated Angelica Pills Distributors List Table 112. Concentrated Angelica Pills Customers List Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources Table 116. Primary Sources List of Figures Figure 1. Concentrated Angelica Pills Product Image Figure 2. Global Concentrated Angelica Pills Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Concentrated Angelica Pills Sales Value (2021-2032) & (US$ Million) Figure 4. Global Concentrated Angelica Pills Sales (2021-2032) & (K Units) Figure 5. Global Concentrated Angelica Pills Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Concentrated Angelica Pills Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Eastern Danggui Image Figure 10. European Danggui Image Figure 11. Global Concentrated Angelica Pills Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Concentrated Angelica Pills Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Concentrated Angelica Pills Sales Volume Share by Type (2021-2032) Figure 14. Global Concentrated Angelica Pills Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Concentrated Angelica Pills Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Concentrated Angelica Pills Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Pharmacy Image Figure 20. Global Concentrated Angelica Pills Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Concentrated Angelica Pills Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Concentrated Angelica Pills Sales Volume Share by Application (2021-2032) Figure 23. Global Concentrated Angelica Pills Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Concentrated Angelica Pills Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Concentrated Angelica Pills Sales Value Share by Application (2021-2032) Figure 26. Global Concentrated Angelica Pills Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Concentrated Angelica Pills Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Concentrated Angelica Pills Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Concentrated Angelica Pills Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Concentrated Angelica Pills Sales Value (2021-2032) & (US$ Million) Figure 31. North America Concentrated Angelica Pills Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Concentrated Angelica Pills Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Concentrated Angelica Pills Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Concentrated Angelica Pills Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Concentrated Angelica Pills Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Concentrated Angelica Pills Sales Value (2021-2032) & (US$ Million) Figure 37. South America Concentrated Angelica Pills Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Concentrated Angelica Pills Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Concentrated Angelica Pills Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Concentrated Angelica Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Concentrated Angelica Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Concentrated Angelica Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Concentrated Angelica Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Concentrated Angelica Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Concentrated Angelica Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Concentrated Angelica Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Concentrated Angelica Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Concentrated Angelica Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Concentrated Angelica Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Concentrated Angelica Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Concentrated Angelica Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Concentrated Angelica Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Concentrated Angelica Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Concentrated Angelica Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Concentrated Angelica Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Concentrated Angelica Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Concentrated Angelica Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Concentrated Angelica Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Concentrated Angelica Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Concentrated Angelica Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Concentrated Angelica Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Concentrated Angelica Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Concentrated Angelica Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Concentrated Angelica Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Concentrated Angelica Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Concentrated Angelica Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Concentrated Angelica Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Concentrated Angelica Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Concentrated Angelica Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Concentrated Angelica Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Concentrated Angelica Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Concentrated Angelica Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Concentrated Angelica Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Concentrated Angelica Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Concentrated Angelica Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Concentrated Angelica Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Concentrated Angelica Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Concentrated Angelica Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Concentrated Angelica Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Concentrated Angelica Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Concentrated Angelica Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Concentrated Angelica Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Concentrated Angelica Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Concentrated Angelica Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Concentrated Angelica Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Concentrated Angelica Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Concentrated Angelica Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Concentrated Angelica Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Concentrated Angelica Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Concentrated Angelica Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Concentrated Angelica Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Concentrated Angelica Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Concentrated Angelica Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Concentrated Angelica Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Concentrated Angelica Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Concentrated Angelica Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Concentrated Angelica Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Concentrated Angelica Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Concentrated Angelica Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Concentrated Angelica Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Concentrated Angelica Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Concentrated Angelica Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Concentrated Angelica Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Concentrated Angelica Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Concentrated Angelica Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Concentrated Angelica Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Concentrated Angelica Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Concentrated Angelica Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Concentrated Angelica Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Concentrated Angelica Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Concentrated Angelica Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Concentrated Angelica Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Concentrated Angelica Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Concentrated Angelica Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Concentrated Angelica Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Concentrated Angelica Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Concentrated Angelica Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Concentrated Angelica Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Concentrated Angelica Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Concentrated Angelica Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Concentrated Angelica Pills Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Concentrated Angelica Pills Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Concentrated Angelica Pills Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Concentrated Angelica Pills Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Concentrated Angelica Pills Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Eastern Danggui
  • European Danggui
Applications
  • Hospital
  • Clinic
  • Pharmacy
Companies covered
  • BAOSHANG GROUP
  • Beijing Hygeia Medical Technique
  • BEIJING TONG REN TANG
  • Gansu Hexi Pharmaceutical
  • Gansu Minzhou Industrial Group
  • Gansu Pharmaceutical Group
  • Guangdong Fengchun Pharmaceutical
  • Lanzhou Foci Pharmaceutical
  • Zhongjing Wanxi Pharmacentical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Concentrated Angelica Pills Sales Value (2021-2032)
  4. 1.2.2 Global Concentrated Angelica Pills Sales Volume (2021-2032)
  5. 1.2.3 Global Concentrated Angelica Pills Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Concentrated Angelica Pills Market Dynamics
  1. 2.1 Concentrated Angelica Pills Industry Trends
  2. 2.2 Concentrated Angelica Pills Industry Drivers
  3. 2.3 Concentrated Angelica Pills Industry Opportunities and Challenges
  4. 2.4 Concentrated Angelica Pills Industry Restraints
3 Concentrated Angelica Pills Market by Company
  1. 3.1 Global Concentrated Angelica Pills Company Revenue Ranking in 2025
  2. 3.2 Global Concentrated Angelica Pills Revenue by Company (2021-2026)
  3. 3.3 Global Concentrated Angelica Pills Sales Volume by Company (2021-2026)
  4. 3.4 Global Concentrated Angelica Pills Average Price by Company (2021-2026)
  5. 3.5 Global Concentrated Angelica Pills Company Ranking (2024-2026)
  6. 3.6 Global Concentrated Angelica Pills Company Manufacturing Base and Headquarters
  7. 3.7 Global Concentrated Angelica Pills Company Product Type and Application
  8. 3.8 Global Concentrated Angelica Pills Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Concentrated Angelica Pills Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Concentrated Angelica Pills Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Concentrated Angelica Pills Market by Type
  1. 4.1 Concentrated Angelica Pills Type Introduction
  2. 4.1.1 Eastern Danggui
  3. 4.1.2 European Danggui
  4. 4.2 Global Concentrated Angelica Pills Sales Volume by Type
  5. 4.2.1 Global Concentrated Angelica Pills Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Concentrated Angelica Pills Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Concentrated Angelica Pills Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Concentrated Angelica Pills Sales Value by Type
  9. 4.3.1 Global Concentrated Angelica Pills Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Concentrated Angelica Pills Sales Value by Type (2021-2032)
  11. 4.3.3 Global Concentrated Angelica Pills Sales Value Share by Type (2021-2032)
5 Concentrated Angelica Pills Market by Application
  1. 5.1 Concentrated Angelica Pills Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Pharmacy
  5. 5.2 Global Concentrated Angelica Pills Sales Volume by Application
  6. 5.2.1 Global Concentrated Angelica Pills Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Concentrated Angelica Pills Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Concentrated Angelica Pills Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Concentrated Angelica Pills Sales Value by Application
  10. 5.3.1 Global Concentrated Angelica Pills Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Concentrated Angelica Pills Sales Value by Application (2021-2032)
  12. 5.3.3 Global Concentrated Angelica Pills Sales Value Share by Application (2021-2032)
6 Concentrated Angelica Pills Regional Sales and Value Analysis
  1. 6.1 Global Concentrated Angelica Pills Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Concentrated Angelica Pills Sales by Region (2021-2032)
  3. 6.2.1 Global Concentrated Angelica Pills Sales by Region: 2021-2026
  4. 6.2.2 Global Concentrated Angelica Pills Sales by Region (2027-2032)
  5. 6.3 Global Concentrated Angelica Pills Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Concentrated Angelica Pills Sales Value by Region (2021-2032)
  7. 6.4.1 Global Concentrated Angelica Pills Sales Value by Region: 2021-2026
  8. 6.4.2 Global Concentrated Angelica Pills Sales Value by Region (2027-2032)
  9. 6.5 Global Concentrated Angelica Pills Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Concentrated Angelica Pills Sales Value (2021-2032)
  12. 6.6.2 North America Concentrated Angelica Pills Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Concentrated Angelica Pills Sales Value (2021-2032)
  15. 6.7.2 Europe Concentrated Angelica Pills Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Concentrated Angelica Pills Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Concentrated Angelica Pills Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Concentrated Angelica Pills Sales Value (2021-2032)
  21. 6.9.2 South America Concentrated Angelica Pills Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Concentrated Angelica Pills Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Concentrated Angelica Pills Sales Value Share by Country, 2025 VS 2032
7 Concentrated Angelica Pills Country-level Sales and Value Analysis
  1. 7.1 Global Concentrated Angelica Pills Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Concentrated Angelica Pills Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Concentrated Angelica Pills Sales by Country (2021-2032)
  4. 7.3.1 Global Concentrated Angelica Pills Sales by Country (2021-2026)
  5. 7.3.2 Global Concentrated Angelica Pills Sales by Country (2027-2032)
  6. 7.4 Global Concentrated Angelica Pills Sales Value by Country (2021-2032)
  7. 7.4.1 Global Concentrated Angelica Pills Sales Value by Country (2021-2026)
  8. 7.4.2 Global Concentrated Angelica Pills Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Concentrated Angelica Pills Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Concentrated Angelica Pills Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Concentrated Angelica Pills Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Concentrated Angelica Pills Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Concentrated Angelica Pills Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Concentrated Angelica Pills Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Concentrated Angelica Pills Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Concentrated Angelica Pills Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Concentrated Angelica Pills Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Concentrated Angelica Pills Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Concentrated Angelica Pills Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Concentrated Angelica Pills Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Concentrated Angelica Pills Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Concentrated Angelica Pills Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Concentrated Angelica Pills Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Concentrated Angelica Pills Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Concentrated Angelica Pills Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Concentrated Angelica Pills Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Concentrated Angelica Pills Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Concentrated Angelica Pills Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Concentrated Angelica Pills Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Concentrated Angelica Pills Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Concentrated Angelica Pills Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Concentrated Angelica Pills Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Concentrated Angelica Pills Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Concentrated Angelica Pills Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Concentrated Angelica Pills Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Concentrated Angelica Pills Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Concentrated Angelica Pills Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Concentrated Angelica Pills Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Concentrated Angelica Pills Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Concentrated Angelica Pills Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Concentrated Angelica Pills Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Concentrated Angelica Pills Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Concentrated Angelica Pills Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Concentrated Angelica Pills Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Concentrated Angelica Pills Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Concentrated Angelica Pills Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Concentrated Angelica Pills Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Concentrated Angelica Pills Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Concentrated Angelica Pills Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Concentrated Angelica Pills Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Concentrated Angelica Pills Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Concentrated Angelica Pills Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Concentrated Angelica Pills Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Concentrated Angelica Pills Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Concentrated Angelica Pills Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Concentrated Angelica Pills Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Concentrated Angelica Pills Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Concentrated Angelica Pills Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Concentrated Angelica Pills Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Concentrated Angelica Pills Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Concentrated Angelica Pills Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Concentrated Angelica Pills Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Concentrated Angelica Pills Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Concentrated Angelica Pills Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Concentrated Angelica Pills Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Concentrated Angelica Pills Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Concentrated Angelica Pills Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Concentrated Angelica Pills Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Concentrated Angelica Pills Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Concentrated Angelica Pills Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Concentrated Angelica Pills Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Concentrated Angelica Pills Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Concentrated Angelica Pills Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Concentrated Angelica Pills Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Concentrated Angelica Pills Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Concentrated Angelica Pills Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Concentrated Angelica Pills Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Concentrated Angelica Pills Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Concentrated Angelica Pills Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Concentrated Angelica Pills Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Concentrated Angelica Pills Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Concentrated Angelica Pills Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Concentrated Angelica Pills Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Concentrated Angelica Pills Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Concentrated Angelica Pills Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Concentrated Angelica Pills Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Concentrated Angelica Pills Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Concentrated Angelica Pills Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Concentrated Angelica Pills Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Concentrated Angelica Pills Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Concentrated Angelica Pills Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Concentrated Angelica Pills Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 BAOSHANG GROUP
  2. 8.1.1 BAOSHANG GROUP Company Information
  3. 8.1.2 BAOSHANG GROUP Business Overview
  4. 8.1.3 BAOSHANG GROUP Concentrated Angelica Pills Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 BAOSHANG GROUP Concentrated Angelica Pills Product Portfolio
  6. 8.1.5 BAOSHANG GROUP Recent Developments
  7. 8.2 Beijing Hygeia Medical Technique
  8. 8.2.1 Beijing Hygeia Medical Technique Company Information
  9. 8.2.2 Beijing Hygeia Medical Technique Business Overview
  10. 8.2.3 Beijing Hygeia Medical Technique Concentrated Angelica Pills Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Beijing Hygeia Medical Technique Concentrated Angelica Pills Product Portfolio
  12. 8.2.5 Beijing Hygeia Medical Technique Recent Developments
  13. 8.3 BEIJING TONG REN TANG
  14. 8.3.1 BEIJING TONG REN TANG Company Information
  15. 8.3.2 BEIJING TONG REN TANG Business Overview
  16. 8.3.3 BEIJING TONG REN TANG Concentrated Angelica Pills Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 BEIJING TONG REN TANG Concentrated Angelica Pills Product Portfolio
  18. 8.3.5 BEIJING TONG REN TANG Recent Developments
  19. 8.4 Gansu Hexi Pharmaceutical
  20. 8.4.1 Gansu Hexi Pharmaceutical Company Information
  21. 8.4.2 Gansu Hexi Pharmaceutical Business Overview
  22. 8.4.3 Gansu Hexi Pharmaceutical Concentrated Angelica Pills Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Gansu Hexi Pharmaceutical Concentrated Angelica Pills Product Portfolio
  24. 8.4.5 Gansu Hexi Pharmaceutical Recent Developments
  25. 8.5 Gansu Minzhou Industrial Group
  26. 8.5.1 Gansu Minzhou Industrial Group Company Information
  27. 8.5.2 Gansu Minzhou Industrial Group Business Overview
  28. 8.5.3 Gansu Minzhou Industrial Group Concentrated Angelica Pills Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Gansu Minzhou Industrial Group Concentrated Angelica Pills Product Portfolio
  30. 8.5.5 Gansu Minzhou Industrial Group Recent Developments
  31. 8.6 Gansu Pharmaceutical Group
  32. 8.6.1 Gansu Pharmaceutical Group Company Information
  33. 8.6.2 Gansu Pharmaceutical Group Business Overview
  34. 8.6.3 Gansu Pharmaceutical Group Concentrated Angelica Pills Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Gansu Pharmaceutical Group Concentrated Angelica Pills Product Portfolio
  36. 8.6.5 Gansu Pharmaceutical Group Recent Developments
  37. 8.7 Guangdong Fengchun Pharmaceutical
  38. 8.7.1 Guangdong Fengchun Pharmaceutical Company Information
  39. 8.7.2 Guangdong Fengchun Pharmaceutical Business Overview
  40. 8.7.3 Guangdong Fengchun Pharmaceutical Concentrated Angelica Pills Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Guangdong Fengchun Pharmaceutical Concentrated Angelica Pills Product Portfolio
  42. 8.7.5 Guangdong Fengchun Pharmaceutical Recent Developments
  43. 8.8 Lanzhou Foci Pharmaceutical
  44. 8.8.1 Lanzhou Foci Pharmaceutical Company Information
  45. 8.8.2 Lanzhou Foci Pharmaceutical Business Overview
  46. 8.8.3 Lanzhou Foci Pharmaceutical Concentrated Angelica Pills Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Lanzhou Foci Pharmaceutical Concentrated Angelica Pills Product Portfolio
  48. 8.8.5 Lanzhou Foci Pharmaceutical Recent Developments
  49. 8.9 Zhongjing Wanxi Pharmacentical
  50. 8.9.1 Zhongjing Wanxi Pharmacentical Company Information
  51. 8.9.2 Zhongjing Wanxi Pharmacentical Business Overview
  52. 8.9.3 Zhongjing Wanxi Pharmacentical Concentrated Angelica Pills Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Zhongjing Wanxi Pharmacentical Concentrated Angelica Pills Product Portfolio
  54. 8.9.5 Zhongjing Wanxi Pharmacentical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Concentrated Angelica Pills Value Chain Analysis
  2. 9.1.1 Concentrated Angelica Pills Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Concentrated Angelica Pills Sales Mode & Process
  6. 9.2 Concentrated Angelica Pills Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Concentrated Angelica Pills Distributors
  9. 9.2.3 Concentrated Angelica Pills Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst